{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:17:59Z","timestamp":1777317479035,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,19]],"date-time":"2010-06-19T00:00:00Z","timestamp":1276905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10875-010-9439-9","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T04:31:55Z","timestamp":1276835515000},"page":"676-680","source":"Crossref","is-referenced-by-count":14,"title":["Inhibitor I\u03baB\u03b1 Promoter Functional Polymorphisms in Patients with Rheumatoid Arthritis"],"prefix":"10.1007","volume":"30","author":[{"given":"Ruei-Nian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Hsien","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,19]]},"reference":[{"key":"9439_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361.","journal-title":"Nature"},{"key":"9439_CR2","first-page":"3","volume":"65","author":"CO Bingham 3rd","year":"2002","unstructured":"Bingham CO 3rd. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Suppl. 2002;65:3\u20139.","journal-title":"J Rheumatol Suppl"},{"key":"9439_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5","volume":"46","author":"FM Brennan","year":"2002","unstructured":"Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum. 2002;46:31\u201341.","journal-title":"Arthritis Rheum"},{"key":"9439_CR4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/ard.2006.067793","volume":"66","author":"SM Dai","year":"2007","unstructured":"Dai SM, Shan ZZ, Xu H, Nishioka K. Cellular targets of interleukin-18 in rheumatoid arthritis. Ann Rheum Dis. 2007;66:1411\u20138.","journal-title":"Ann Rheum Dis"},{"key":"9439_CR5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429\u201342.","journal-title":"Nat Rev Immunol"},{"key":"9439_CR6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066\u201371.","journal-title":"N Engl J Med"},{"key":"9439_CR7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1172\/JCI8298","volume":"105","author":"IK Campbell","year":"2000","unstructured":"Campbell IK, Gerondakis S, O'Donnell K, Wicks IP. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest. 2000;105:1799\u2013806.","journal-title":"J Clin Invest"},{"key":"9439_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1357-4310(00)01814-1","volume":"6","author":"SS Makarov","year":"2000","unstructured":"Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today. 2000;6:441\u20138.","journal-title":"Mol Med Today"},{"key":"9439_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7\u201311.","journal-title":"J Clin Invest"},{"key":"9439_CR10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1567-5769(02)00058-9","volume":"2","author":"T Wang","year":"2002","unstructured":"Wang T, Zhang X, Li JJ. The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol. 2002;2:1509\u201320.","journal-title":"Int Immunopharmacol"},{"key":"9439_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","volume":"5","author":"LF Chen","year":"2004","unstructured":"Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol. 2004;5:392\u2013401.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9439_CR12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725\u201334.","journal-title":"Nat Rev Immunol"},{"key":"9439_CR13","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V94.9.3129","volume":"94","author":"F Emmerich","year":"1999","unstructured":"Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, et al. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood. 1999;94:3129\u201334.","journal-title":"Blood"},{"key":"9439_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.febslet.2004.11.060","volume":"579","author":"K Iwai","year":"2005","unstructured":"Iwai K, Lee BR, Hashiguchi M, Fukushima A, Iwashima M. IkB-alpha-specific transcript regulation by the C-terminal end of c-Rel. FEBS Lett. 2005;579:141\u20134.","journal-title":"FEBS Lett"},{"key":"9439_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2172-10-3","volume":"10","author":"C Ortutay","year":"2009","unstructured":"Ortutay C, Vihinen M. Immunome knowledge base (IKB): an integrated service for immunome research. BMC Immunol. 2009;10:3.","journal-title":"BMC Immunol"},{"key":"9439_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/scbi.1997.0058","volume":"8","author":"ST Whiteside","year":"1997","unstructured":"Whiteside ST, Israel A. I kappa B proteins: structure, function and regulation. Semin Cancer Biol. 1997;8:75\u201382.","journal-title":"Semin Cancer Biol"},{"key":"9439_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0300-9475.2004.01505.x","volume":"60","author":"H Cheon","year":"2004","unstructured":"Cheon H, Sun YK, Yu SJ, Lee YH, Ji JD, Song GG, et al. Platelet-derived growth factor-AA increases IL-1beta and IL-8 expression and activates NF-kappaB in rheumatoid fibroblast-like synoviocytes. Scand J Immunol. 2004;60:455\u201362.","journal-title":"Scand J Immunol"},{"key":"9439_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1744-313X.2007.00660.x","volume":"34","author":"CH Lin","year":"2007","unstructured":"Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis. Int J Immunogenet. 2007;34:51\u20134.","journal-title":"Int J Immunogenet"},{"key":"9439_CR19","first-page":"1440","volume":"32","author":"Y Okazaki","year":"2005","unstructured":"Okazaki Y, Sawada T, Nagatani K, Komagata Y, Inoue T, Muto S, et al. Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol. 2005;32:1440\u20137.","journal-title":"J Rheumatol"},{"key":"9439_CR20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.gene.6364001","volume":"4","author":"A Abdallah","year":"2003","unstructured":"Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, et al. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 2003;4:450\u20134.","journal-title":"Genes Immun"},{"key":"9439_CR21","doi-asserted-by":"crossref","unstructured":"Hung YH, Ou TT, Lin CH, Li RN, Lin YC, Tsai WC, et al. IkBalpha promoter polymorphisms in patients with ankylosing spondylitis. Rheumatol Int. 2009.","DOI":"10.1007\/s00296-009-0923-6"},{"key":"9439_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.gene.6363753","volume":"2","author":"N Mozzato-Chamay","year":"2001","unstructured":"Mozzato-Chamay N, Corbett EL, Bailey RL, Mabey DC, Raynes J, Conway DJ. Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun. 2001;2:153\u20135.","journal-title":"Genes Immun"},{"key":"9439_CR23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","volume":"44","author":"PP Tak","year":"2001","unstructured":"Tak PP, Gerlag DM, Aupperle KR, van de Geest DA, Overbeek M, Bennett BL, et al. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum. 2001;44:1897\u2013907.","journal-title":"Arthritis Rheum"},{"key":"9439_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10875-007-9156-1","volume":"28","author":"CH Lin","year":"2008","unstructured":"Lin CH, Wang SC, Ou TT, Li RN, Tsai WC, Liu HW, et al. I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus. J Clin Immunol. 2008;28:207\u201313.","journal-title":"J Clin Immunol"},{"key":"9439_CR25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10875-008-9212-5","volume":"28","author":"TT Ou","year":"2008","unstructured":"Ou TT, Lin CH, Lin YC, Li RN, Tsai WC, Liu HW, et al. IkappaBalpha promoter polymorphisms in patients with primary Sjogren's syndrome. J Clin Immunol. 2008;28:440\u20134.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9439-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-010-9439-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9439-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T22:26:02Z","timestamp":1591395962000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-010-9439-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,19]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9439"],"URL":"https:\/\/doi.org\/10.1007\/s10875-010-9439-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,19]]}}}